|
⚲
|
| Keyboard |
| John Reher | |
|---|---|
| Firm | |
| Address | c/o Chase Therapeutics Corporation 1825 K Streeet NW, Suite 510 Washington, DC 20006 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Chase Therapeutics Corp | 021-320230 | Director | 4.0 M of 4.0 M |
||
| Brainscope Company Inc | 021-295689 | Director | 16.4 M of 16.4 M |
||
| Chase Pharmaceuticals Corp | 021-260084 | Director | 12.0 M of 12.0 M |
||
| Brain Trust Accelerator Fund II LP | 021-260033 | Executive Officer | 12.0 M of 20.0 M |
||
| Chase Pharmaceuticals Corp | 021-257591 | Director | of 0.1 M |
||
| Chase Pharmaceuticals Corp | 021-257589 | Director | of 0.6 M |
||
| Brainscope Company Inc | 021-247013 | Director | 2.5 M of 2.9 M |
||
| Chase Pharmaceuticals Corp | 021-246193 | Director | 3.5 M of 3.5 M |
||
| Chase Pharmaceuticals Corp | 021-218283 | Director | 6.1 M of 8.6 M |
||
| Chase Pharmaceuticals Corp | 021-153008 | Director | 1.2 M of 1.2 M |
||
| Brainscope Company Inc | 021-152524 | Director | 16.5 M of 16.5 M |
||
| Brainscope Company Inc | 021-92051 | Director | 2.4 M of 4.0 M |
||